Baseline characteristics of the patients
| Characteristic | Budesonide group (n=59) | Placebo group (n=58) | |||||
|---|---|---|---|---|---|---|---|
| Mean | Range | Mean | Range | ||||
| Sex (M/F) | 28/31 | 20/38 | |||||
| Race (Caucasian/mixed) | 54/5 | 53/5 | |||||
| Age (y) | 35 | (19–71) | 32 | (18–66) | |||
| Height (cm) | 169 | (154–193) | 168 | (148–187) | |||
| Weight (kg) | 67 | (46–91) | 65 | (42–106) | |||
| CDAI | 103 | (−14–208) | 109 | (−50–192) | |||
| Disease duration (y) | 8.9 | (1–25) | 8.1 | (1–26) | |||
| Disease site (ileum/ileocaecal/colon) | 28/29/2 | 30/28/0 | |||||
| Previous resection (yes/no) | 18/41 | 21/37 | |||||
| Time since resection (y) | 3.7 | (0–14) | 4.5 | (0–15) | |||
| Mean length of resection (cm) | 34 | (0–80) | 46 | (15–100) | |||
| Use of 5-ASA | 29 | 28 | |||||
| Mean dose among users (g) | 2.8 | 2.7 | |||||
| Use of azathioprine | 9 | 5 | |||||
| Mean dose among users (mg) | 139 | 115 | |||||
| Initial prednisolone dose (mg) | 16.5 | (10–30) | 15.7 | (10–30) | |||
| No of patients with initial dose <15/15–<20/20–30 mg | 28/7/24 | 29/8/21 | |||||